glp-1 afib GLP‑1 Therapy Improves Atrial Fibrillation Outcomes After Catheter Ablation, Miller School Study Finds New research presented at #HRS2026
Description
The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation
This enzyme helps regulate how cells use and store energy, promoting more efficient fat and carbohydrate metabolism and supporting balanced blood sugar levels
Attorneys at Morgan & Morgan have taken legal action against the makers of Ozempic, one of the most popular diabetes and weight loss drugs on the market.
The one in eight Americans currently using GLP-1s, like Ozempic, are considering pausing their drugs for the holidays
How do lipedema patients respond to GLP-1 RAs
The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition
